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Background/aim: The aim of the present study was to evaluate the etiology and clinical and pathological behavior of solitary fibrous
tumors of the pleura (SFTPs), as well as the most appropriate surgical approach and the results of long-term follow-up of this condition.
Materials and methods: Clinical and long-term follow-up records of 14 patients who had surgery for SFTP between 2001 and 2014 were
reviewed retrospectively. Etiological factors, diagnostic procedures, and clinical courses and outcomes for these patients were studied.
Results: Of the 14 patients, 8 were male (57%) and 6 were female (43%) patients. The mean age was 54.14 ± 10.35 (41–75) years. There
was no remarkable common etiological factor. Preoperative diagnosis was achieved only in 2 patients. Predominant symptoms were
cough and chest pain. Complete resection was achieved in all patients. Video-assisted thoracic surgery (VATS) was performed in 8
patients. All but one patient were classified as having benign SFTP. The mean follow-up was 58.5 ± 41.4 (10–132) months and no
recurrence was noted in the follow-up.
Conclusion: These rarely seen tumors of the pleura are usually benign and asymptomatic and their preoperative diagnosis is difficult.
Clinical and pathological behavior is still unpredictable and the treatment consists of complete resection. Minimally invasive techniques
such as VATS are recommended for surgery if the tumor size is appropriate.
Key words: Solitary fibrous tumor, pleura, etiology, diagnosis, treatment

1. Introduction
Primary tumors of the pleura are classified as diffuse
and solitary. The solitary form was thought to be a
form of mesothelioma and received different names
such as localized mesothelioma, subpleural fibroma,
benign mesothelioma, and subserous fibroma (1,2). It is
recognized that the solitary fibrous tumor of the pleura
(SFTP), which is rare and grows slowly, originates from
mesenchymal cells of the submesothelial tissue of the
pleura (3,4). No reports have demonstrated a correlation
between SFTP and exposure to asbestos or any other
carcinogens (5,6). Over 80% of these tumors are benign
(1,4,7). They mostly appear between the 4th and 7th
decades of life, half of them are asymptomatic, and they
manifest as rounded, homogeneous masses with smooth
margins on routine radiograms (8,9). Preoperative
diagnosis is difficult because of nonspecific radiographic
findings, and complete resection is the best prognostic
factor (10–13).
The aim of the present study was to identify any common
or remarkable etiological factor or any biochemical
* Correspondence: dr_aliozdil@yahoo.com
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abnormality or clinical presentation of SFTP, as well as
to examine the best appropriate surgical approach and
the results of long-term follow-up, and to compare these
parameters with those reported in the literature.
2. Materials and methods
Between January 2001 and October 2014 the clinical and
long-term follow-up records of 14 patients who had had
surgery for SFTP were reviewed retrospectively. Common
etiological factors, diagnostic procedures, and the clinical
courses and outcomes for these patients were evaluated.
The diagnosis of SFTP was confirmed by histomorphologic
and immunohistochemical staining with hematoxylin/
eosin, CD34, vimentin, and cytokeratin. Malignancy
criteria were described by England et al. (14) as more
than 4 mitoses per 10 high-power fields, the presence of
necrosis, and nuclear crowding and overlapping, which
was defined as high cellularity and nuclear atypia. When
one or more of these criteria was found histologically,
the fibrous tumor was categorized as malignant (2,4).
The classification of staging was based on de Perrot et al.
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Table 1. Classification of solitary fibrous tumors of the pleura according to the staging
proposed in de Perrot et al. (2).
Stage 0

Pedunculated tumor without signs of malignancy

Stage I

Sessile or “inverted” tumor without signs of malignancy

Stage II

Pedunculated tumor with histologic signs of malignancy

Stage III

Sessile or “inverted” tumor with histologic signs of malignancy

Stage IV

Multiple synchronous metastatic tumors

(2) (Table 1). All patients were included in a follow-up
program with clinical and radiographic examinations.

With the exception of 1 hyperglycemic patient who
had diabetes mellitus, there were no abnormalities in
laboratory findings. The tumor was on the left side in 6
patients. On preoperative computed tomography (CT),
SFTP was predefined in only 5 patients, lung cancer was
described in 8, and hematoma was suspected in 1 patient
because of a history of blunt thoracic trauma.
Five patients underwent preoperative diagnostic
invasive procedures: 2 of them were reported as having
SFTP, another 2 were diagnosed with nonspecific
histology, and 1 patient was mistakenly prediagnosed with
nonsmall-cell lung carcinoma.

3. Results
There were 8 male (57%) and 6 female (43%) patients with
a mean age of 54.1 ± 10.4 (41–75) years. Seven patients
(50%) were asymptomatic. The predominant symptoms
for symptomatic patients were cough and chest pain.
One patient had a history of thyroid carcinoma and 1
patient was diagnosed with endometrium carcinoma. The
demographical and clinical characteristics of the patients
are given in Table 2.
Table 2. Demographic and clinical characteristics of the patients.
Case

Age

Sex

Additional disease

Laboratory
abnormality

Symptom

Side

Pleural
origin

Tumor
size (mm)

Incision

Follow-up
(months)

1

53

M

-

-

-

Right

Parietal

95 × 60

LT

132

2

54

M

COLD

-

Cough
Chest pain

Left

Visceral

40 × 25

VATS

110

3

51

F

Thyroid carcinoma

-

-

Right

Visceral

40 × 30

VATS

106

4

59

F

-

-

-

Left

Visceral

40 × 40

LT

102

Left

Visceral

40 × 35

VATS

91

5

66

M

DM+HT

Hyperglycemia

Cough
Dizziness

6

41

M

Blunt thorax
trauma

-

-

Left

Visceral

120 × 75

PLT

55

7

45

F

Endometrium
carcinoma

-

Chest pain

Right

Visceral

60 × 40

VATS

50

8

49

F

Bile stone

-

-

Right

Visceral

30 × 35

LT

45

9

45

F

-

Hypercholesterolemia

Chest pain

Right

Parietal

20 × 16

VATS

38

10

75

M

HT

-

Cough

Left

Visceral

70 × 70

VATS

29

11

52

M

Hyperlipidemia

Hyperglycemia +
hypercholesterolemia

Chest pain

Right

Visceral

55 × 40

VATS

20

12

40

M

-

-

-

Right

Visceral

15 × 10

VATS

17

13

61

F

HT

High blood sedimentation

Back and right
arm pain

Right

Visceral

60 × 50

LT

14

14

67

M

DM+HT+BPH

Hypercholesterolemia

-

Left

Visceral

65 × 50

LT

10

M: male, F: female, COLD: chronic obstructive lung disease, DM: diabetes mellitus, HT: hypertension, BPH: benign prostatic hypertrophy, VATS: video-assisted thoracic
surgery, VAST: video-assisted small thoracotomy, LT: lateral thoracotomy, PLT: posterolateral thoracotomy.
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Five patients underwent muscle sparing lateral
thoracotomy and 1 patient underwent posterolateral
thoracotomy. The videothoracoscopic approach was used
in 7 patients. In 1 patient the excision was started with
video-assisted thoracoscopy, but for removing the large
tumor completely a utility thoracotomy was added.
Upon surgical exploration it was determined that the
tumor originated from the visceral pleura in 10 patients
(71.42%); among them a pedicle was present in 7 patients.
All 14 tumors showed high vascularity. There was no local
invasion and complete resection was performed in all
patients. The mean tumor diameter was 53.6 ± 28.5 (20–
120) mm. In histopathological examination, all patients
were positive for CD34 and vimentin and negative for
cytokeratin. All except 1 patient were diagnosed with
benign solitary fibrous tumors. Seven patients were
stage 0, 6 patients were stage 1, and 1 patient was stage 3
according to the classification reported in de Perrot et al.
(2) (Table 3).
There were no preoperative or postoperative mortalities
and no major complications. Minimum and maximum
follow-up times were 10 and 132 months, respectively. The
mean follow-up was 58.5 ± 41.5 months and no recurrence
was determined in radiographic controls.
Table 3. Staging of the cases.
Patient

Base

Behaviora

Stageb

1

Cecile

Benign

I

2

Cecile

Benign

I

3

Pedunculated

Benign

0

4

Cecile

Benign

I

5

Pedunculated

Benign

0

6

Pedunculated

Benign

0

7

Pedunculated

Benign

0

8

Pedunculated

Benign

0

9

Cecile

Benign

1

10

Cecile

Malign

3

11

Cecile

Benign

1

12

Pedunculated

Benign

0

13

Pedunculated

Benign

0

14

Cecile

Benign

1

a: According to the criteria described in England et al. (14).
b: According to the staging proposed in de Perrot et al. (2).
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4. Discussion
Primary tumors of the pleura were described by Lieutaud
in 1767 and classified as diffuse and localized by Klemperer
and Rabin in 1931 (1). Only 5% of neoplasms that arise
from the pleura are SFTP and have been reported between
the ages of 5 and 87; the incidence is only 2.8 cases per
100,000 (7,8).
Solitary fibrous tumors are rarely seen tumors, and
therefore the weakness of this study is the small number of
patients, although this is one of the major series published
about SFTP. Still more studies are needed to clarify the
etiology and nonsurgical diagnostic alternatives of this
rare pathology.
Environmental agents or genetically transmitted germline mutations may play a role in its etiology according to
the literature, but no consistent chromosomal abnormality
has been reported (9). Similar to 1 case in the current
study, it has been reported that history of trauma can
overshadow the exact pathogenesis (12).
The clinical behavior of solitary fibrous tumors is
unpredictable. Half of the patients are asymptomatic
and are recognized with routine radiograms (1,8,15).
On the other hand, the most common symptoms are
cough and chest pain (11,12). Other rare symptoms are
fever, more than 10% body weight loss, pleural effusion,
hypertrophic osteoarthropathy, clubbing, galactorrhea,
and hypoglycemia that disappears in 3 to 4 days after
surgery (3,16–18). None of these rare symptoms and
laboratory findings was seen in our patients.
Radiographic examinations reveal these tumors
as solitary, well-circumscribed, sometimes lobulated,
generally noninvasive tumors with a size range from
1 to 40 cm (1,2,7,10). Serous pleural effusion has been
reported in a malignant group (7,10). Radiographic signs
are nonspecific. Unusually, lesions can be multicentric
(4,19,20).
Pathologically, a SFTP diagnosis is confirmed by
typical histomorphologic findings of a solid spindle cell
component and a diffuse sclerosing component combined
with immunohistochemical staining positive for vimentin
and/or CD34, and negative for keratin and/or S-100
protein (10).
Eighty percent of SFTPs originate from the visceral
pleura, but the parietal pleura, mediastinal pleura,
diaphragm, and chest wall may be the origin in some cases
(3,6). In our series, heterogeneous findings on CT support
the idea that the variety of origins affects preoperative
diagnosis negatively. The CT diagnosis of SFTP depends
on a high index of suspicion and on the experience of the
radiologist.
Preoperative fine needle aspiration and tru-cut biopsy
is not recommended because of insufficient diagnostic
value (6,8,10). In our series, only 2 cases from 5 patients
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who had undergone preoperative diagnostic invasive
procedures were reported as SFTP.
These tumors are attached to the pleura by a
highly vascular pedicle in 50% of cases and sometimes
preoperative angiographic embolization can be applied
because of hypervascularity (3,6,21). Excision should be
done carefully due to the possibility of bleeding during
surgery (5,6,18,21). The intrathoracic cavity had to be
thoroughly observed due to the multicentricity and contact
metastasis of the tumors (19). In our series, especially in
cases with large tumors, lots of vascular vessels up to 0.8
cm in diameter were explored and divided intraoperatively.
The surgical approach can change due to the size and
origin of the tumor, but videothoracoscopy is recommended
as the choice of resection for all pedunculated tumors and
lesions smaller than 5 cm (3,4,10).
Large tumors can also be treated by videothoracoscopy,
whereas a utility thoracotomy can be added for the removal
of the tumors, similar to 1 case in our study (13,22).
A safety margin of at least 1 to 2 cm from normal
tissue is recommended for excision (2,6,8). Occasionally
resection of the tumor is sufficient for treatment, but
mandatory extended approaches such as lobectomy,
pneumonectomy, or partial resection of the chest wall or
diaphragm were applied because of the size of the tumor or
local invasion in some studies (4,11,22). In contradiction
with the literature, complete resection was obtained with
excision of the tumor in all of our cases.
Malignant SFTPs do not reflect their clinical behavior
(6,8,12). Some studies remarked on the possibility of
malignancy in gross lesions (9,11). De Perrot et al. (2)
suggested that tumor size could not be a malignancy
criterion. A benign tumor with a diameter of 12 cm in our
study supports this recommendation.

Complete resection is the mainstay of therapy for both
benign and malignant tumors and cure rates are 100% for
benign and 50% for malignant lesions (2,3,21). The most
important good prognostic factors are histological benign
variant, pedunculated tumors, and small size (4). Based
on the staging system proposed by de Perrot et al. (2), a
predominance of stage 0 was revealed (13). Similar to the
literature, disease-free survival for all of our patients was
100%, because of the characteristics such as benign type
and pedunculated (3,15).
Local recurrence can be found in 2%–10% of cases,
but this rate is decreased in pedunculated lesions (1,2,11).
A long follow-up should be carried out because of the
high risk of recurrence (8). However, the factors that
are predictive of recurrence have yet to be specified and
require additional immunohistochemical and genetic
investigations (23). In cases of recurrence, surgical
resection is the best choice of treatment (6,7,10). Adjuvant
therapies are not recommended if complete resection
has been done, but some authors suggest the use of
radiotherapy when resection is incomplete (2,3,11). There
is no standard protocol about postoperative chemotherapy
or radiotherapy (6).
In conclusion, SFTPs are unusual and their etiology is
yet undefined. Preoperative diagnosis is difficult because
of the absence of marked signs, symptoms, or laboratory
findings. Complete surgical resection is still the best
method for both diagnosis and treatment. We recommend
the videothoracoscopic approach even in the case of a
large tumor. However, the dissection should be performed
carefully, especially if the tumor is large, if there is a thick
pedicle, or in nonpedunculated tumors because of the high
vascularity of these tumors.
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